Keyphrases
Fatty Acid Oxidation
100%
Antimycin A
100%
3T3-L1
100%
Triglyceride Accumulation
100%
Fat Metabolism
66%
Specific Marker
33%
Mitochondrial Impairment
33%
Carnitine Palmitoyltransferase 1A (CPT1A)
33%
Glucose Transporter 4 (GLUT4)
33%
ChREBP
33%
Receptor Activity
33%
Peroxisome Proliferator-activated Receptor
33%
Direct Conversion
33%
Molecular Signaling
33%
Cell-mediated
33%
Multiple Symmetric Lipomatosis
33%
Plasma Membrane
33%
Mitochondrial Cytopathy
33%
Multivesicular
33%
Mitochondrial Respiration
33%
Dysregulation
33%
Lipogenic Transcription Factor
33%
Glucose Uptake
33%
Lipid Metabolism
33%
Disease-associated
33%
AKT1
33%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Acid
100%
Triacylglycerol
100%
Antimycin A
60%
MERRF Syndrome
20%
Peroxisome Proliferator Activated Receptor
20%
Disorders of Mitochondrial Functions
20%
Carnitine Palmitoyltransferase I
20%
Lipomatosis
20%
Glucose Transporter 4
20%
Biochemistry, Genetics and Molecular Biology
3T3-L1
100%
Mitochondrial Respiration
20%
Carbohydrate-Responsive Element-Binding Protein
20%
Carnitine Palmitoyltransferase I
20%
MERRF Syndrome
20%
Lipomatosis
20%
Peroxisome Proliferator-Activated Receptor
20%
Mitochondrion
20%
INIS
antimycin
42%
fats
28%
carnitine
14%
epilepsy
14%
translocation
14%
transferases
14%
Medicine and Dentistry
Lipid Metabolism
60%
Adipocyte
40%
Carnitine Palmitoyltransferase I
20%